FNDC5 and sarcopenia: In postmenopausal women, irisin can be used as a biomarker for sarcopenia and hip fracture, because irisin is inversely related to the degree of muscle wasting and the risk of hip fractures (Yan et al., 2018; Park et al., 2019; Ruan et al., 2020).